• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒病对脂肪组织特征的影响

Consequences of COVID-19 on Adipose Tissue Signatures.

作者信息

Krupka Sontje, Hoffmann Anne, Jasaszwili Mariami, Dietrich Arne, Guiu-Jurado Esther, Klöting Nora, Blüher Matthias

机构信息

Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Helmholtz Zentrum München, University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany.

Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04103 Leipzig, Germany.

出版信息

Int J Mol Sci. 2024 Mar 2;25(5):2908. doi: 10.3390/ijms25052908.

DOI:10.3390/ijms25052908
PMID:38474155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10932458/
Abstract

Since the emergence of coronavirus disease-19 (COVID-19) in 2019, it has been crucial to investigate the causes of severe cases, particularly the higher rates of hospitalization and mortality in individuals with obesity. Previous findings suggest that adipocytes may play a role in adverse COVID-19 outcomes in people with obesity. The impact of COVID-19 vaccination and infection on adipose tissue (AT) is currently unclear. We therefore analyzed 27 paired biopsies of visceral and subcutaneous AT from donors of the Leipzig Obesity BioBank that have been categorized into three groups (1: no infection/no vaccination; 2: no infection but vaccinated; 3: infected and vaccinated) based on COVID-19 antibodies to spike (indicating vaccination) and/or nucleocapsid proteins. We provide additional insights into the impact of COVID-19 on AT biology through a comprehensive histological transcriptome and serum proteome analysis. This study demonstrates that COVID-19 infection is associated with smaller average adipocyte size. The impact of infection on gene expression was significantly more pronounced in subcutaneous than in visceral AT and mainly due to immune system-related processes. Serum proteome analysis revealed the effects of the infection on circulating adiponectin, interleukin 6 (IL-6), and carbonic anhydrase 5A (CA5A), which are all related to obesity and blood glucose abnormalities.

摘要

自2019年冠状病毒病(COVID-19)出现以来,调查重症病例的病因至关重要,尤其是肥胖个体住院率和死亡率较高的情况。先前的研究结果表明,脂肪细胞可能在肥胖人群COVID-19不良结局中发挥作用。目前尚不清楚COVID-19疫苗接种和感染对脂肪组织(AT)的影响。因此,我们分析了来自莱比锡肥胖生物样本库供体的27对内脏和皮下脂肪组织活检样本,这些样本根据针对刺突蛋白(表明接种疫苗)和/或核衣壳蛋白的COVID-19抗体被分为三组(1:未感染/未接种疫苗;2:未感染但接种了疫苗;3:感染且接种了疫苗)。我们通过全面的组织学转录组和血清蛋白质组分析,进一步深入了解COVID-19对脂肪组织生物学的影响。这项研究表明,COVID-19感染与平均脂肪细胞尺寸较小有关。感染对基因表达的影响在皮下脂肪组织中比在内脏脂肪组织中更为明显,主要是由于与免疫系统相关的过程。血清蛋白质组分析揭示了感染对循环脂联素、白细胞介素6(IL-6)和碳酸酐酶5A(CA5A)的影响,这些都与肥胖和血糖异常有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/352868308d1c/ijms-25-02908-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/a4b2249c32e5/ijms-25-02908-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/3b5a61b45b76/ijms-25-02908-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/de4d3ddfb154/ijms-25-02908-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/dbd140dc7081/ijms-25-02908-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/0596a3db221d/ijms-25-02908-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/198b67e31673/ijms-25-02908-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/352868308d1c/ijms-25-02908-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/a4b2249c32e5/ijms-25-02908-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/3b5a61b45b76/ijms-25-02908-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/de4d3ddfb154/ijms-25-02908-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/dbd140dc7081/ijms-25-02908-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/0596a3db221d/ijms-25-02908-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/198b67e31673/ijms-25-02908-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b25/10932458/352868308d1c/ijms-25-02908-g007.jpg

相似文献

1
Consequences of COVID-19 on Adipose Tissue Signatures.新冠病毒病对脂肪组织特征的影响
Int J Mol Sci. 2024 Mar 2;25(5):2908. doi: 10.3390/ijms25052908.
2
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.严重肥胖人群对 SARS-CoV-2 疫苗的抗体反应。
Obes Surg. 2022 Sep;32(9):2987-2993. doi: 10.1007/s11695-022-06181-y. Epub 2022 Jul 8.
3
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
4
Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.肥胖的 COVID-19 患者死亡率较高,可能与高凝状态和脂肪组织炎症加重有关。
Front Endocrinol (Lausanne). 2020 Jul 28;11:530. doi: 10.3389/fendo.2020.00530. eCollection 2020.
5
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
6
A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity.肥胖与 COVID-19 疫苗诱导的中和性体液免疫效力降低之间可能存在关联。
J Med Virol. 2023 Jan;95(1):e28130. doi: 10.1002/jmv.28130. Epub 2022 Sep 14.
7
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.既往感染与疫苗接种产生针对 SARS-CoV-2 变异株的中和抗体效力。
mBio. 2021 Dec 21;12(6):e0265621. doi: 10.1128/mBio.02656-21. Epub 2021 Dec 7.
8
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
9
Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19.脂肪组织可能通过 GRP78(BIP/HSPA5)参与老年、肥胖和糖尿病合并 SARS-CoV-2 感染(COVID-19)患者:COVID-19 中高胰岛素血症管理的意义。
Diabetes. 2021 Dec;70(12):2745-2755. doi: 10.2337/db20-1094. Epub 2021 Oct 6.
10
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.

引用本文的文献

1
Depot-specific acetylation profiles of adipose tissues-therapeutic targets for metabolically unhealthy obesity.脂肪组织特定储存部位的乙酰化谱——代谢不健康型肥胖的治疗靶点
Diabetol Metab Syndr. 2025 Jan 29;17(1):36. doi: 10.1186/s13098-025-01599-7.
2
New Insights into Adipose Tissue Metabolic Function and Dysfunction, 2nd Edition.《脂肪组织代谢功能与障碍的新见解》第 2 版。
Int J Mol Sci. 2024 Aug 27;25(17):9258. doi: 10.3390/ijms25179258.
3
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.

本文引用的文献

1
Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects.SARS-CoV-2 感染期间的脂质代谢调节:聚焦细胞外囊泡和治疗前景。
Int J Mol Sci. 2024 Jan 4;25(1):640. doi: 10.3390/ijms25010640.
2
Diabetes Mellitus, Energy Metabolism, and COVID-19.糖尿病、能量代谢与 COVID-19
Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032.
3
Does adipose tissue contribute to acute infection-related inflammation in COVID-19?脂肪组织是否会导致新冠病毒感染相关的急性炎症?
应对癌症患者的新冠后急性综合征,从内脏肥胖和肌少脂变到全身炎症:对心脏肿瘤代谢的影响
Biomedicines. 2024 Jul 24;12(8):1650. doi: 10.3390/biomedicines12081650.
Nutr Metab Cardiovasc Dis. 2023 Dec;33(12):2527-2528. doi: 10.1016/j.numecd.2023.07.029. Epub 2023 Aug 5.
4
Hyperinflammatory Immune Response in COVID-19: Host Genetic Factors in Pyrin Inflammasome and Immunity to Virus in a Spanish Population from Majorca Island.新冠病毒感染中的高炎症免疫反应:来自马略卡岛的西班牙人群中吡喃素炎性小体的宿主遗传因素及对病毒的免疫
Biomedicines. 2023 Sep 16;11(9):2548. doi: 10.3390/biomedicines11092548.
5
Mechanisms and pathophysiology of SARS-CoV-2 infection of the adipose tissue.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染脂肪组织的机制与病理生理学
Trends Endocrinol Metab. 2023 Nov;34(11):735-748. doi: 10.1016/j.tem.2023.08.010. Epub 2023 Sep 4.
6
Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation.抑制 SREBP 通路可预防 SARS-CoV-2 复制和炎症小体激活。
Life Sci Alliance. 2023 Sep 5;6(11). doi: 10.26508/lsa.202302049. Print 2023 Nov.
7
Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform.通过Olink蛋白质组学平台鉴定急性心肌梗死的新型候选生物标志物
Clin Chim Acta. 2023 Aug 1;548:117506. doi: 10.1016/j.cca.2023.117506. Epub 2023 Aug 6.
8
Organokines in COVID-19: A Systematic Review.COVID-19 中的器官激酶:系统评价。
Cells. 2023 May 9;12(10):1349. doi: 10.3390/cells12101349.
9
Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study.血浆蛋白质组学与 2 型糖尿病及其相关特征的关联:来自纵向 KORA S4/F4/FF4 研究的结果。
Diabetologia. 2023 Sep;66(9):1655-1668. doi: 10.1007/s00125-023-05943-2. Epub 2023 Jun 13.
10
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic.在 COVID-19 大流行期间,住院的糖尿病患者低血糖和高血糖的发生率增加。
J Diabetes Complications. 2023 Jul;37(7):108474. doi: 10.1016/j.jdiacomp.2023.108474. Epub 2023 Apr 14.